Voting Rights and Shares Capital of the Company | NBTX Stock News

Apr 14, 2025

Nanobiotix (NBTX, Financial) reports 47,426,851 shares outstanding as of March 31, 2025.
The company disclosed 49,193,374 theoretical voting rights and 49,171,256 exercisable voting rights.
This disclosure complies with French regulatory requirements, including the French Commercial Code and the Financial Markets Authority regulations.

Nanobiotix (NBTX), a leader in biotechnological innovations, has released its latest voting rights and share capital statement effective March 31, 2025. According to the report, the company has 47,426,851 shares outstanding.

The statement also indicates that Nanobiotix has a total of 49,193,374 theoretical voting rights and 49,171,256 exercisable voting rights. The difference of 22,118 voting rights arises from shares where rights are currently suspended, adhering to Article 223-11 of the AMF General Regulations.

Nanobiotix is listed on both Euronext Paris and the Nasdaq Global Select Market. The disclosure aligns with the French regulatory frameworks, including the mandates from the French Commercial Code and the Autorité des Marchés Financiers.

For more information, visit their official website at www.nanobiotix.com.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.